News + Filings Transactions Holdings
|
Venrock Healthcare Capital Partners II, L.P.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Aclaris Therapeutics, Inc.
| ACRS | COM | 45,639,622 | 45,639,622 | 859,394,082 | 859,394,082 | | |
Hist
| 01/19/2021 |
RELMADA THERAPEUTICS, INC.
| RLMD | Common | 22,700,722 | 22,032,282 | 747,307,768 | 725,870,897 | | |
Hist
| 03/26/2021 |
Cogent Biosciences, Inc.
| COGT | Common | 43,021,262 | 43,021,262 | 369,122,428 | 369,122,428 | | |
Hist
| 12/31/2021 |
Vistagen Therapeutics, Inc.
| VTGN | Common | 160,472,862 | 18,070,490 | 312,922,081 | 36,661,479 | | |
Hist
| 12/31/2021 |
Tricida, Inc.
| TCDA | Common | 34,948,512 | 34,948,512 | 268,055,087 | 268,055,087 | | |
Hist
| 11/17/2021 |
Axsome Therapeutics, Inc.
| AXSM | COM | 2,333,975 | 693,975 | 241,239,656 | 227,857,256 | | |
Hist
| 12/31/2019 |
Athira Pharma, Inc.
| ATHA | Common | 10,000,002 | 10,000,002 | 130,300,026 | 130,300,026 | | |
Hist
| 12/31/2021 |
Cogent Biosciences, Inc.
| UMRX | Common | 18,872,182 | 18,872,182 | 56,805,268 | 56,805,268 | | |
Hist
| 07/09/2020 |
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 6,310,255 | 6,310,255 | 50,923,758 | 50,923,758 | | |
Hist
| 12/31/2018 |
HUMANIGEN, INC
| HGEN | Common | 17,241,379 | 17,241,379 | 43,793,103 | 43,793,103 | | |
Hist
| 06/02/2020 |
Aadi Bioscience, Inc.
| AADI | Common | 15,294,022 | 15,294,022 | 33,646,848 | 33,646,848 | | |
Hist
| 08/26/2021 |
MARINUS PHARMACEUTICALS, INC.
| MRNS | Common | 2,588,941 | -3,913,899 | 31,585,080 | 17,538,946 | | |
Hist
| 12/31/2020 |
ENDOCYTE INC
| ECYT | COM | 4,300,000 | 4,300,000 | 25,499,000 | 25,499,000 | | |
Hist
| 02/28/2018 |
Sierra Oncology, Inc.
| SRRA | Common | 984,746 | 984,746 | 21,408,378 | 21,408,378 | | |
Hist
| 12/31/2021 |
Protagonist Therapeutics, Inc
| PTGX | Common | 1,499,129 | 1,499,129 | 17,689,722 | 17,689,722 | | |
Hist
| 06/07/2019 |
KalVista Pharmaceuticals, Inc.
| KALV | Common | 986,173 | -207,939 | 17,563,741 | 7,443,642 | | |
Hist
| 12/31/2019 |
Surface Oncology, Inc.
| SURF | Common | 1,442,895 | 1,442,895 | 13,332,350 | 13,332,350 | | |
Hist
| 12/31/2020 |
LA JOLLA PHARMACEUTICAL CO
| LJPC | Common | 1,375,000 | 1,375,000 | 8,497,500 | 8,497,500 | | |
Hist
| 02/01/2019 |
CATALYST BIOSCIENCES, INC.
| CBIO | Common | 340,676 | 340,676 | 6,639,775 | 6,639,775 | | |
Hist
| 01/19/2018 |
Corvus Pharmaceuticals, Inc.
| CRVS | COM | 2,500,002 | 2,500,002 | 6,025,005 | 6,025,005 | | |
Hist
| 12/31/2021 |
|
|
|
|